• Home
  • Industry
  • Innovation
  • Market
  • Materials
  • Products
  • Subscribe
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Lost your password?
Forgotten Password
Cancel
  • Home
  • Industry
  • Products
  • Materials
  • Innovation
  • Market
  • Sustainability
  • Regulatory
  • About Us
    • President’s Message
    • The Chemical Daily
  • Subscribe
    • Q & A
    • Manage my Subscription
  • 日本語
    • 化学工業日報
    • 広告掲載について

Coronavirus Report – Part 13: Japanese Companies Start to Develop Vaccines, Treatments

Mar. 10, 2020

Filed Under: Coronavirus, Pharma Tagged With: AnGes, Chugai Pharmaceutical, coronavirus, Fujifilm Toyama Chemical, Osaka University, Takara Bio, Takeda Pharmaceutical, Teijin Pharma, vaccines

Japan is starting up development for a number of vaccines and treatments to deal with the novel coronavirus. One effort…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Coronavirus Report – Part 89: Japanese Materials and Chemicals Companies See Rush of Contract Production Activity
Coronavirus Report – Part 89: Japanese Materials and…
Just How Effective Will Vaccines Be in Combating the COVID-19 Pandemic?
Just How Effective Will Vaccines Be in Combating the…
Column: COVID-19 Brings Major Changes to Vaccine Development
Column: COVID-19 Brings Major Changes to Vaccine Development
Taiwan Looks to Establish CDMOs for mRNA Technology
Taiwan Looks to Establish CDMOs for mRNA Technology
Spate of Japanese-Developed COVID-19 Vaccines Head Into Later Stages of Development, Clinical Trials
Spate of Japanese-Developed COVID-19 Vaccines Head Into…
Coronavirus Report – Part 91: GSK Japan President Paul Lirette Discusses Strategy and Moves in Pandemic Times
Coronavirus Report – Part 91: GSK Japan President Paul…
Previous Post: « Coronavirus Report – Part 12: Movement of Labor, Resources Becomes an Increasingly Big Issue
Next Post: Kaneka Speeds up Application Development for PHBH Biodegradable Polymer »

Primary Sidebar

Latest Articles

Sumco Considers Further Expansion to Deal With Demand From 2027 Onward

Jun. 30, 2022

Ube Sees Starch-Based PA Adopted in Europe

Jun. 30, 2022

Arkema Lines up Asian Boost to Production Capacity for Bio-Based PA

Jun. 30, 2022

Mitsui Chemicals Looks to Enter Sepsis Diagnostics Market

Jun. 30, 2022

AGC Aims to Expand Agrochemical CDMO Business by Developing Active Ingredients to Rival China

Jun. 30, 2022

Most Popular

  • Yachiyo Develops Plastic Hydrogen Tanks
  • Japan’s Ethylene Production Down for 2016, Operation Rates Remain High
  • Mitsubishi Chemical to Commercialize Chemical Recycling of PMMA
  • Toray Develops New Aramid Film With High Transparency, Hardness, Flexibility
  • Interview with Dr. Maureen Tan, Deputy Executive Director, Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR)

Tags

asahi kasei Automotive automotive materials batteries china CO2 CO2 emissions coronavirus electric vehicles environment ethylene EV health care industry trends interview investments LiB LiB materials M&A market conditions medical METI Mitsubishi Chemical Mitsubishi Chemical Holdings Mitsui Chemicals new facilities new materials petrochemical pharmaceutical polypropylene production production increase R&D recycling semiconductors Showa Denko strategy Sumitomo Chemical supply and demand Teijin thailand Toray tosoh U.S. ube industries

Footer

Log In


Lost your password?
Forgotten Password
Cancel

Links

Home
About
広告掲載について
Terms of Use
Privacy Policy
Legal Notice
Notation on the Specified Commercial Transaction Act
Contact us

© 2016–2022 The Chemical Daily Co. Ltd., Bonuterra Inc. All Rights Reserved.

japan-industry-news-network_logo

Copyright © 2023 · Chemical Daily v2 on Genesis Framework · WordPress · Log in